CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy

Annals of Surgical Oncology

Volumn 16, Issue 9, 2009, Pages 2531-2538

  Nagata, Shigenori ^a   Jin, Yu Fen ^a   Yoshizato, Katsuhiko ^a   Tomoeda, Miki ^a   Song, Misa ^a   Iizuka, Norishige ^a   Kitamura, Masanori ^a   Takahashi, Hidenori ^a   Eguchi, Hidetoshi ^a   Ohigashi, Hiroaki ^a   Ishikawa, Osamu ^a   Tomita, Yasuhiko ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CD74; CANCER ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY SCREENING; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 68949197323     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0532-3     Document Type: Article

References (28)

1. JE Niederhuber MF Brennan HR Menck 1995 The National Cancer Data Base report on pancreatic cancer Cancer. 76 1671 1677
2. KC Conlon DS Klimstra MF Brennan 1996 Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors Ann Surg 223 273 279
3. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun 2008 Cancer statistics, 2008 CA Cancer J Clin. 58 71 96
4. C Gebhardt W Meyer M Reichel PH Wunsch 2000 Prognostic factors in the operative treatment of ductal pancreatic carcinoma Langenbecks Arch Surg. 385 14 20
5. TM Breslin KR Hess DB Harbison et al 2001 Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration Ann Surg Oncol. 8 123 132
6. TB Brunner GG Grabenbauer T Meyer H Golcher R Sauer W Hohenberger 2007 Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomized phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO) BMC Cancer. 7 41
7. DB Evans GR Varadhachary CH Crane et al 2008 Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol. 26 3496 3502
8. H Ohigashi O Ishikawa H Eguchi et al 2005 Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head Ann Surg Oncol. 12 629 636
9. O Ishikawa H Ohigashi Y Sasaki K Masao T Kabuto H Furukawa S Imaoka 1998 Adjuvant therapies in extended pancreatectomy for ductal adenocarcinoma of the pancreas Hepatogastroenterology. 45 644 650
10. H Uyama Y Tomita H Nakamura et al 2006 Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer Clin Cancer Res. 12 6043 6048
11. HL Ioachim SE Pambuccian M Hekimgil FR Giancotti BH Dorsett 1996 Lymphoid monoclonal antibodies reactive with lung tumors. Diagnostic applications Am J Surg Pathol. 20 64 71
12. R Lazova R Moynes D May G Scott 1997 LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma Cancer 79 2115 2124
13. AN Young MB Amin CS Moreno et al 2001 Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers Am J Pathol. 158 1639 1651
14. Y Hippo M Yashiro M Ishii et al 2001 Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes Cancer Res. 61 889 895
15. Z Jiang M Xu L Savas P LeClair BF Banner 1999 Invariant chain expression in colon neoplasms Virchows Arch. 435 32 36
16. SR Hustinx D Cao A Maitra et al 2004 Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression Cancer Biol Ther. 3 1254 1261
17. N Koide T Yamada R Shibata et al 2006 Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer Clin Cancer Res. 12 2419 2426
18. A Castells P Puig J Mora et al 1999 K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance J Clin Oncol. 17 578 584
19. M Niedergethmann M Rexin R Hildenbrand S Knob JW Sturm A Richter S Post 2002 Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma Am J Surg Pathol. 26 1578 1587
20. S Yamamoto Y Tomita Y Hoshida et al 2004 Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma Clin Cancer Res. 10 2846 2850
21. PA Roche P Cresswell 1990 Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding Nature. 345 615 618
22. PA Morton ML Zacheis KS Giacoletto JA Manning BD Schwartz 1995 Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells J Immunol. 154 137 150
23. R Stein MJ Mattes TM Cardillo et al 2007 CD74: a new candidate target for the immunotherapy of B-cell neoplasms Clin Cancer Res. 13 5556s 5563s
24. GL Griffiths MJ Mattes R Stein SV Govindan ID Horak HJ Hansen DM Goldenberg 2003 Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate Clin Cancer Res. 9 6567 6571
25. JD Burton S Ely PK Reddy R Stein DV Gold TM Cardillo DM Goldenberg 2004 CD74 is expressed by multiple myeloma and is a promising target for therapy Clin Cancer Res. 10 6606 6611
26. RB Michel AV Rosario PM Andrews DM Goldenberg MJ Mattes 2005 Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons Clin Cancer Res. 11 777 786
27. ME Chamuleau Y Souwer SM Van Ham et al 2004 Class II-associated invariant chain peptide expression on myeloid leukemic blasts predicts poor clinical outcome Cancer Res. 64 5546 5550
28. DB Evans TA Rich DR Byrd et al 1992 Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg. 127 1335 1339